Viatris (VTRS) Gross Profit Growth (1y) (2021 - 2026)
Powered by 
Analysis
Viatris (VTRS) Gross Profit Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.43% |
| 2 | Viatris | 19.20 Bn | 18.31 Bn | 1.46 Bn | 9.27% |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.73 Bn | 396.53 Mn | -30.21% |
| 4 | Amneal Pharmaceuticals | 5.49 Bn | 5.36 Bn | 334.51 Mn | 16.86% |
| 5 | Bausch Health Companies | 2.31 Bn | 475.75 Mn | 2.10 Bn | 17.79% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 21.30% |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 711.29 Mn | 93.47 Mn | 8.07% |
| 9 | Fennec Pharmaceuticals | 396.40 Mn | 355.15 Mn | 17.15 Mn | 97.50% |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.27% |
| Mar 31, 2026 | -0.34% |
| Dec 31, 2025 | -5.52% |
| Sep 30, 2025 | -6.01% |
| Jun 30, 2025 | -7.78% |
| Mar 31, 2025 | -22.79% |
| Dec 31, 2024 | -23.90% |
| Sep 30, 2024 | -13.72% |
| Jun 30, 2024 | -10.15% |
| Mar 31, 2024 | -2.48% |
| Dec 31, 2023 | 25.30% |
| Sep 30, 2023 | -3.27% |
| Jun 30, 2023 | -5.56% |
| Mar 31, 2023 | -12.93% |
| Dec 31, 2022 | -17.61% |
| Sep 30, 2022 | 11.07% |
| Jun 30, 2022 | 28.29% |
| Mar 31, 2022 | 57.12% |
| Dec 31, 2021 | 118.91% |
| Mar 31, 2021 | 24.41% |